vs

Side-by-side financial comparison of CORCEPT THERAPEUTICS INC (CORT) and Hess Midstream LP (HESM). Click either name above to swap in a different company.

Hess Midstream LP is the larger business by last-quarter revenue ($404.2M vs $202.1M, roughly 2.0× CORCEPT THERAPEUTICS INC). Hess Midstream LP runs the higher net margin — 23.1% vs 12.0%, a 11.1% gap on every dollar of revenue. On growth, CORCEPT THERAPEUTICS INC posted the faster year-over-year revenue change (11.1% vs 2.1%). Hess Midstream LP produced more free cash flow last quarter ($178.9M vs $38.4M). Over the past eight quarters, CORCEPT THERAPEUTICS INC's revenue compounded faster (17.3% CAGR vs 6.6%).

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Hess Corporation is an American global independent energy company involved in the exploration and production of crude oil and natural gas. It was formed by the merger of Hess Oil and Chemical and Amerada Petroleum in 1968. Leon Hess was CEO from the early 1960s until 1995, after which his son John B Hess succeeded him as chairman and CEO. The company agreed to be acquired by rival oil company Chevron in October 2023, and the acquisition closed in July 2025.

CORT vs HESM — Head-to-Head

Bigger by revenue
HESM
HESM
2.0× larger
HESM
$404.2M
$202.1M
CORT
Growing faster (revenue YoY)
CORT
CORT
+9.0% gap
CORT
11.1%
2.1%
HESM
Higher net margin
HESM
HESM
11.1% more per $
HESM
23.1%
12.0%
CORT
More free cash flow
HESM
HESM
$140.5M more FCF
HESM
$178.9M
$38.4M
CORT
Faster 2-yr revenue CAGR
CORT
CORT
Annualised
CORT
17.3%
6.6%
HESM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CORT
CORT
HESM
HESM
Revenue
$202.1M
$404.2M
Net Profit
$24.3M
$93.3M
Gross Margin
98.7%
Operating Margin
2.2%
62.2%
Net Margin
12.0%
23.1%
Revenue YoY
11.1%
2.1%
Net Profit YoY
-21.0%
32.5%
EPS (diluted)
$0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CORT
CORT
HESM
HESM
Q4 25
$202.1M
$404.2M
Q3 25
$207.6M
$420.9M
Q2 25
$194.4M
$414.2M
Q1 25
$157.2M
$382.0M
Q4 24
$181.9M
$395.9M
Q3 24
$182.5M
$378.5M
Q2 24
$163.8M
$365.5M
Q1 24
$146.8M
$355.6M
Net Profit
CORT
CORT
HESM
HESM
Q4 25
$24.3M
$93.3M
Q3 25
$19.7M
$97.7M
Q2 25
$35.1M
$90.3M
Q1 25
$20.5M
$71.6M
Q4 24
$30.7M
$70.4M
Q3 24
$47.2M
$58.6M
Q2 24
$35.5M
$49.5M
Q1 24
$27.8M
$44.6M
Gross Margin
CORT
CORT
HESM
HESM
Q4 25
98.7%
Q3 25
97.8%
Q2 25
98.2%
Q1 25
98.5%
Q4 24
98.4%
Q3 24
98.4%
Q2 24
98.5%
Q1 24
98.3%
Operating Margin
CORT
CORT
HESM
HESM
Q4 25
2.2%
62.2%
Q3 25
4.9%
61.5%
Q2 25
13.7%
62.8%
Q1 25
2.2%
62.1%
Q4 24
13.9%
61.4%
Q3 24
25.5%
61.2%
Q2 24
21.7%
60.8%
Q1 24
20.1%
62.4%
Net Margin
CORT
CORT
HESM
HESM
Q4 25
12.0%
23.1%
Q3 25
9.5%
23.2%
Q2 25
18.1%
21.8%
Q1 25
13.1%
18.7%
Q4 24
16.9%
17.8%
Q3 24
25.9%
15.5%
Q2 24
21.7%
13.5%
Q1 24
18.9%
12.5%
EPS (diluted)
CORT
CORT
HESM
HESM
Q4 25
$0.20
Q3 25
$0.16
Q2 25
$0.29
Q1 25
$0.17
Q4 24
$0.25
Q3 24
$0.41
Q2 24
$0.32
Q1 24
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CORT
CORT
HESM
HESM
Cash + ST InvestmentsLiquidity on hand
$372.2M
$1.9M
Total DebtLower is stronger
$3.8B
Stockholders' EquityBook value
$647.8M
Total Assets
$836.7M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CORT
CORT
HESM
HESM
Q4 25
$372.2M
$1.9M
Q3 25
$421.7M
$5.5M
Q2 25
$342.2M
$4.5M
Q1 25
$322.8M
$6.1M
Q4 24
$383.3M
$4.3M
Q3 24
$380.3M
$10.3M
Q2 24
$473.2M
$99.6M
Q1 24
$410.8M
$4.2M
Total Debt
CORT
CORT
HESM
HESM
Q4 25
$3.8B
Q3 25
Q2 25
Q1 25
Q4 24
$3.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CORT
CORT
HESM
HESM
Q4 25
$647.8M
Q3 25
$631.9M
Q2 25
$635.8M
Q1 25
$683.3M
Q4 24
$679.6M
Q3 24
$638.8M
Q2 24
$596.2M
Q1 24
$547.9M
Total Assets
CORT
CORT
HESM
HESM
Q4 25
$836.7M
$4.4B
Q3 25
$823.6M
$4.4B
Q2 25
$801.7M
$4.4B
Q1 25
$846.5M
$4.3B
Q4 24
$840.6M
$4.2B
Q3 24
$784.3M
$4.1B
Q2 24
$714.6M
$4.1B
Q1 24
$655.9M
$3.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CORT
CORT
HESM
HESM
Operating Cash FlowLast quarter
$38.4M
$245.6M
Free Cash FlowOCF − Capex
$38.4M
$178.9M
FCF MarginFCF / Revenue
19.0%
44.3%
Capex IntensityCapex / Revenue
0.0%
16.5%
Cash ConversionOCF / Net Profit
1.58×
2.63×
TTM Free Cash FlowTrailing 4 quarters
$728.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CORT
CORT
HESM
HESM
Q4 25
$38.4M
$245.6M
Q3 25
$54.5M
$258.9M
Q2 25
$43.9M
$276.9M
Q1 25
$5.1M
$202.4M
Q4 24
$59.3M
$258.5M
Q3 24
$73.8M
$224.9M
Q2 24
$41.2M
$271.6M
Q1 24
$23.8M
$185.3M
Free Cash Flow
CORT
CORT
HESM
HESM
Q4 25
$38.4M
$178.9M
Q3 25
$178.9M
Q2 25
$43.9M
$213.5M
Q1 25
$5.0M
$156.9M
Q4 24
$59.2M
$163.4M
Q3 24
$72.2M
$132.6M
Q2 24
$40.8M
$207.7M
Q1 24
$130.5M
FCF Margin
CORT
CORT
HESM
HESM
Q4 25
19.0%
44.3%
Q3 25
42.5%
Q2 25
22.6%
51.5%
Q1 25
3.2%
41.1%
Q4 24
32.5%
41.3%
Q3 24
39.5%
35.0%
Q2 24
24.9%
56.8%
Q1 24
36.7%
Capex Intensity
CORT
CORT
HESM
HESM
Q4 25
0.0%
16.5%
Q3 25
0.0%
19.0%
Q2 25
0.0%
15.3%
Q1 25
0.1%
11.9%
Q4 24
0.1%
24.0%
Q3 24
0.9%
24.4%
Q2 24
0.3%
17.5%
Q1 24
0.0%
15.4%
Cash Conversion
CORT
CORT
HESM
HESM
Q4 25
1.58×
2.63×
Q3 25
2.77×
2.65×
Q2 25
1.25×
3.07×
Q1 25
0.25×
2.83×
Q4 24
1.93×
3.67×
Q3 24
1.56×
3.84×
Q2 24
1.16×
5.49×
Q1 24
0.86×
4.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CORT
CORT

Segment breakdown not available.

HESM
HESM

Gathering$217.3M54%
Processing And Storage$154.7M38%
Terminaling And Export$32.2M8%

Related Comparisons